ZIM Labs inks pact with Globalpharma Co to commercialise oral thin film products

ZIM Laboratories Ltd,a research-driven pharmaceutical company focused on differentiated oral solid dosage forms, has entered into a Dossier License, Product Supply, and Technology Know-How License Agreement with Globalpharma Co. (L.L.C.), a leading UAE-based pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments, one of the region's premier investment entities.

- 

This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs' proprietary Oral Thin Film technology platform, ThinOral. Under the agreement, Globalpharma will register and commercialize 10 OTF-based Pharmaceutical and Nutraceutical products developed by ZIM, catering to regional patient needs with advanced, user-friendly dosage forms. Initially, ZIM Labs will supply b